Subscribe

    Raj Chovatiya, MD, PhD: Atopic Dermatitis Update 2023

    In a recap of his Maui Derm NP+PA Fall 2023 session, Dr. Chovatiya discusses the array of new drug approvals for AD, including biologics, oral drugs, and topicals, and how to choose between each option for our patients with AD.

    MORE CONFERENCE COVERAGE

    Ted Rosen, MD: Dermatology Literature in Review 2023 
    Dr. Rosen discusses notable papers that he reviewed in his Maui Derm NP+PA Fall Literature Review presentation.
    PLAY
    Jerry Shapiro, MD: Hair Disorders Update 2023
    In a recap of his Maui Derm NP+PA Fall 2023 session, Dr. Shapiro covers the spectrum of hair disorders from non-scarring to scarring alopecias and
    PLAY
    Melodie Young, MSN, ANP-c: Psoriasis Update 2023
    Melodie Young provides a recap of her contribution to the Psoriasis and Psoriatic Arthritis 2023 session presented at Maui Derm NP+PA Fall.
    PLAY
    Victoria Lazareth, MA, MSN, NP-C, DCNP: Advances in Systemic Therapies for Atopic Dermatitis
    Victoria Lazareth discusses how NPs and PAs can gain confidence with treating their patients with new systemic drugs for atopic dermatitis.
    PLAY
    Hilary Baldwin, MD: Acne Update 2023
    In a recap of her Maui Derm NP+PA Fall 2023 session, Dr. Baldwin discussed advances in topical and oral treatments for patients with acne.
    PLAY
    Douglas DiRuggiero, DMSc, PA-C: Contact Dermatitis, Allergic Dermatitis, and Atopic Dermatitis
    o In a recap of his Maui Derm NP+PA Fall 2023 session, Doug DiRuggiero shares insights on diagnosing nonspecific rashes and managing dermatitis in connection
    PLAY
    Matthew Zirwas, MD: Inflammatory Cytokine Inhibition in Atopic Dermatitis Treatment
    Dr. Zirwas provides an enthusiastic overview of how our arsenal of atopic dermatitis treatments work to improve atopic dermatitis.
    PLAY
    Shanna M. Miranti, MPAS, PA: Incorporating New Atopic Dermatitis Therapies into Clinical Practice
    Shanna Miranti discusses how NPs and PAs can improve their patient care by taking advantage of the new options available to clinicians.
    PLAY
    Julie Harper, MD: Rosacea Update
    Dr. Harper recaps her session from Maui Derm NP+PA Fall, in which she discussed moving away from rosacea subtypes as well as new insights in
    PLAY
    Raj Chovatiya, MD, PhD: Atopic Dermatitis Update 2023
    In a recap of his Maui Derm NP+PA Fall 2023 session, Dr. Chovatiya discusses the array of new drug approvals for AD, including biologics, oral
    PLAY
    Victoria Lazareth, MA, MSN, NP-C, DCNP: Surgical Procedural Workshop
    Victoria Lazareth discussed topics covered during the Surgical Procedural Workshop, which took place during the meeting’s Pre-Conference Day.
    PLAY
    Douglas DiRuggiero, DMSc, PA-C: Benefits of Oral JAK Inhibitors for Atopic Dermatitis
    Doug DiRuggiero discusses oral JAK inhibitors for patients with atopic dermatitis and how these new agents will benefit patients with AD.
    PLAY
    Ted Rosen, MD: Infectious Disease Update 2023
    In a recap of his Maui Derm NP+PA Fall 2023 session, Dr. Rosen overviews updates on COVID-19 and long COVID, monkeypox, HIV, and fungal infections.
    PLAY
    Raj Chovatiya, MD, PhD: Safety of Oral JAK Inhibitors for Atopic Dermatitis
    Dr. Chovatiya discusses safety data on upadacitinib and abrocitinib for the treatment of atopic dermatitis.
    PLAY
    Matthew Zirwas, MD: Dermatology Literature in Review 2023
    In a recap of his Maui Derm NP+PA Fall 2023 session, Dr. Zirwas discusses some of the most exciting new papers published this year in
    PLAY

    JCAD

    Journal of Clinical and Aesthetic Dermatology

    Facebook-f X-twitter Instagram Linkedin Youtube Spotify

    ©2026 JCAD | The Journal of Clinical and Aesthetic Dermatology. All Rights Reserved.